Antigen Associated Articles & Analysis
7 articles found
Target Selection: The initial step in ADC development is identifying an appropriate target. Tumor-associated antigens (TAAs) are typically selected based on their expression in cancer cells versus normal tissues. ...
To grasp how cancer vaccines work, it is pivotal to understand two fundamental components of the immune system: antigens and antibodies. Antigens are molecules or molecular structures that evoke an immune response when identified as foreign by the body's immune system. ...
Targets can be divided into tumor-specific antigens (TSA) and tumor-associated antigens (TAA) according to their expression. Antigens that are only expressed in tumor cells but not in normal cells are tumor-specific antigens and the most ideal targets; antigens that are lowly expressed in normal ...
Survivin (SVN) is a member of the inhibitor of apoptosis (IAP) protein family that promotes cellular proliferation and inhibits apoptosis. Overexpression of SVN is associated with autoimmune disease, hyperplasia, and tumors and can be used as a biomarker in these diseases. SVN is widely recognized as a tumor-associated antigen (TAA) and has ...
TCR-engineered T cells express tumor antigen-specific receptors with alpha and beta chains generated from high-quality, high-affinity clones of antigen-specific T cells. ...
Endosomal escape means that mRNA needs to be released from the endosomal vesicles, and then combined with the host cell ribosome to be translated into antigen proteins, which are modified and secreted out of the cell to play a role. ...
Centers for Disease Control (the "CDC"), a vaccine for a specific disease stimulates an individual's immune system, causing it to produce antibodies to counteract the antigens associated with the disease in question, just as one's immune system would do if one were actually exposed to the disease. ...